Vaxxinity Q2 EPS $(0.11) Up From $(0.14) YoY
Portfolio Pulse from Benzinga Newsdesk
Vaxxinity (NASDAQ:VAXX) reported Q2 losses of $(0.11) per share, a 21.43% improvement from $(0.14) per share losses in the same period last year.
August 09, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vaxxinity's Q2 losses per share improved by 21.43% YoY, which could be seen as a positive sign by investors.
Vaxxinity's Q2 earnings report shows a decrease in losses per share compared to the same period last year. This improvement could be seen as a positive sign by investors, potentially leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100